About Us

 

Fragment-Based Approach towards the Design of Potent and Versatile Anti-Cancer Agents

Views (571)
Downloads (0)


Abstract

Despite years of clinical research and trials of encouraging new therapies, cancer remains a leading cause of morbidity and mortality. The fragment-based drug discovery has evolved formerly as an efficient approach for identification, optimization, and generation of lead. After identifying the fragments having binding affinity with the target using computational method for fragment screening, they are optimized into more active compounds. This review elaborates the application of methodology of fragment-based drug design in designing potent and versatile anti-cancer drug candidates. It comprises of details such as construction of fragment library and screening, principles of library design, fragment hit identification, fragment to lead optimization, deconstruction and reconstruction approach, unified fragment based QSAR technique, phytochemical and pharmacophoric fragment based drug development and FBDD based targeting of epigenetic regulators in cancer. The agents discussed include STAT-3 inhibitor, vemurafenib, pazopanib, TAS-116 HSP-90 α/β inhibitor, pexidartinib, venetoclax and erdafitinib, FBDD based designed Anticancer Agents.

Authors

1- Sana Ali Zahra
Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

2-Ayesha Imran
Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

3-Faiza Khalid
Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

4-Mubashir Rehman
Assistant Professor, Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.

Keywords

Fragment-Based Drug Design, Potent and Novel Anti-Cancer Agents, Fragment Optimization, Deconstruction-Reconstruction

DOI Number

10.31703/gdddr.2020(V-I).01


Page Nos

1-14

Volume & Issue

V - I

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Published: Dec 2020

Citation Formats

ABNT   APA   BibTex   MLA   Oxford   Harvard   Chicago   Turabian   AAA   MHRA


Share Article

Google Scholar

Google Scholar

Why Choose Us

Quality of research
We are committed to publish research papers of very good quality so as to improve the impact of our publications on researchers.
Trusted Peer Review
Your article gets the most trustworthy reviews from the top professionals of the field.
Dedicated Team of Editors
We have a very well versed and qualified team of professional editors to publish your research and guide you through out the process.
Global Audience
We have the most comprehensive marketing strategy for sharing your research across the globe.
Multiple Archives
We are committed to preserve our valuable research so we submit it to multiple international archives.
Member of Crossref
Unique identifier is assigned to each article published which improves your discoverability.

Volumes

5

Authors

75

Issue

5

Articles

25